Expression of MAGE-A3 in and histopathological analysis of forceps biopsy specimens of non– small-cell lung carcinoma patients

1 Murray J. Biology of non-small lung cancer. In: Mason R Nadel’s (ed.) Textbook of respiratory medicine. Philadelphia: Elsevier Saunders; 2010. p. 1108–1182. Search in Google Scholar

2 Global Cancer Observatory. Indonesia fact sheets. 2021. Available from: http://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf [Accessed 19th October 2021]. Search in Google Scholar

3 American Cancer Society. Key statistics for lung cancer. 2020. Available from: https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html [Accessed 19th October 2020]. Search in Google Scholar

4 Infodatin. Stop kanker. 2020. Available from: www.depkes.go.id/infodatin-kanker. [Accessed 19th October 2020]. Indonesian. Search in Google Scholar

5 Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, et al. Non-small cell lung cancer, version 6.2015. Journal of the National Comprehensive Cancer Network. 2015;13(5): 515–524. Search in Google Scholar

6 Ho MY, Tang SJ, Sun KH, Yang W. Immunotherapy for lung cancers. Journal of Biomedicine and Biotechnology. 2011;2011: 1–10. Search in Google Scholar

7 Cedrés S, Nuñez I, Longo M, Martinez P, Checa E, Torrejón D, et al. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clinical Lung Cancer. 2011;12(3): 172–179. Search in Google Scholar

8 Hashiyada M. DNA biometrics [Internet]. Biometrics. InTech; 2011. Available from: http://dx.doi.org/10.5772/18139. Search in Google Scholar

9 Kim YD, Park HR, Song MH, Shin DH, Lee CH, Lee MK, et al. Pattern of cancer/testis antigen expression in lung cancer patients. International Journal of Molecular Medicine. 2012;29(4): 656–662. Search in Google Scholar

10 Grah JJ, Katalinic D, Juretic A, Santek F, Samarzija M. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer. Tumori. 2014;100(1): 60–68. Search in Google Scholar

11 Sienel W, Varwerk C, Linder A, Kaiser D, Teschner M, Delire M, et al. Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study. European Journal of Cardio-Thoracic Surgery. 2004;25(1): 131–134. Search in Google Scholar

12 Shigematsu Y, Hanagiri T, Shiota H, Kuroda K, Baba T, Mizukami M, et al. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer. Lung Cancer. 2010;68(1): 105–110. Search in Google Scholar

13 Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, et al. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Research. 2001;61(21): 7959–7963. Search in Google Scholar

14 Bernard PS, Wittwer CT. Real-time PCR technology for cancer diagnostics. Clinical Chemistry. 2002;48(8): 1178–1185. Search in Google Scholar

15 Shital P, Rujuta A, Sanjay M. Transbronchial needle aspiration cytology (TBNA) in endobronchial lesions: A valuable technique during bronchoscopy in diagnosing lung cancer and it will decrease repeat bronchoscopy. Journal of Cancer Research and Clinical Oncology. 2014;140(5): 809–815. Search in Google Scholar

16 Dotson T, Bellinger C, Su J, Hansen K, Parks GE, Cappellari JO, et al. Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial). Lung Cancer. 2019;127: 6–11. Search in Google Scholar

17 Muyal JP, Muyal V, Kaistha BP, Seifart C, Fehrenbach H. Systematic comparison of RNA extraction techniques from frozen and fresh lung tissues: Checkpoint towards gene expression studies. Diagnostic Pathology. 2009;4: 9. Search in Google Scholar

18 Shin KC, Choi EY, Chung JH, Jeon C, Lee KH. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy. Anticancer Research. 2012;32(1): 163–167. Search in Google Scholar

19 Winter H, van den Engel NK, Rusan M, Schupp N, Poehlein CH, Hu HM, et al. Active-specific immunotherapy for non-small cell lung cancer. Journal of Thoracic Disease. 2011;3(2): 105–114. Search in Google Scholar

20 Tsai JR, Chong IW, Chen YH, Yang MJ, Sheu CC, Chang HC, et al. Differential expression profile of MAGE family in non-small-cell lung cancer. Lung Cancer. 2007;56(2): 185–192. Search in Google Scholar

21 Becker HD, Shirakawa T, Tanaka F, Muller KM, Herth F. Trans-bronchial lung biopsy in the immunocompromised patient. European Respiratory Monogr. 1998;9: 193–208. Search in Google Scholar

22 Valones MA, Guimarães RL, Brandão LA, de Souza PR, de Albuquerque Tavares Carvalho A, Crovela S. Principles and applications of polymerase chain reaction in medical diagnostic fields: A review. Brazilian Journal of Microbiology. 2009;40(1): 1–11. Search in Google Scholar

23 Casoni GL, Gurioli C, Chhajed PN, Chilosi M, Zompatori M, Olivieri D, et al. The value of transbronchial lung biopsy using jumbo forceps via rigid bronchoscope in diffuse lung disease. Monaldi Archives for Chest Disease. 2008;69(2): 59–64. Search in Google Scholar

24 Mazzone P, Jain P, Arroliga AC, Matthay RA. Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Chest Medicine Clinics. 2002;23(1): 137–158. Search in Google Scholar

25 Kim HR, Kim TH, Chung JH, Yoon HI, Lee CT, Kang CH, et al. The detection of peripheral lung cancer by MAGE A1-6 RT-nested PCR in bronchial washing specimens. Lung Cancer. 2009;65(2): 166–169. Search in Google Scholar

26 Leaker BR, Nicholson GC, Ali FY, Daudi N, O’Connor BJ, Barnes PJ. Bronchoabsorption; A novel bronchoscopic technique to improve biomarker sampling of the airway. Respiratory Research. 2015;16(1): 102. Search in Google Scholar

27 Karimi S, Mohammadi F, Porabdollah M, Mohajerani SA, Khodadad K, Nadji SA. Characterization of melanoma- associated antigen-a genes family differential expression in non- small-cell lung cancers. Clinical Lung Cancer. 2012;13(3): 214–219. Search in Google Scholar

28 Weynants P, Lethé B, Brasseur F, Marchand M, Boon T. Expression of mage genes by non-small-cell lung carcinomas. International Journal of Cancer. 1994;56(6): 826–829. Search in Google Scholar

29 Shichijo S, Hayashi A, Takamori S, Tsunosue R, Hoshino T, Sakata M, et al. Detection of MAGE-4 protein in lung cancers. International Journal of Cancer. 1995;64(3): 158–165. doi:10.1002/ijc.2910640303. Search in Google Scholar

30 American Cancer Society. Cancer facts & figures. 2020. Available from: https://www.cancer.org/research/cancerfactstatistics.html [Accessed 19th October 2020]. Search in Google Scholar

31 Vansteenkiste JF, Cho BC, Vanakesa T, De Pas T, Zielinski M, Kim MS, et al. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncology. 2016;17(6): 822–835. Search in Google Scholar

32 Yanagawa N, Tamura G, Oizumi H, Endoh M, Motoyama T. MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer. Anticancer Research. 2011;31(1): 171–175. Search in Google Scholar

33 Hara I, Hara S, Miyake H, Yamanaka K, Nagai H, Gohji K, et al. Expression of MAGE genes in testicular germ cell tumors. Urology. 1999;53(4): 843–847. Search in Google Scholar

34 Miranda EI. MAGE, biological functions and potential clinical applications. Leukemia Research. 2010;34(9): 1121–1122. Search in Google Scholar